Clinical Trial Update: Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy

View source ↗

Summary

A Phase I trial tested MR spectroscopy-guided targeting of the dominant intraprostatic lesion with high-dose-rate brachytherapy in prostate cancer; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Status: COMPLETED